Lack of a consistent relationship between demethylation of the CD44 promoter and CD44 expression

被引:6
|
作者
Hyman, R [1 ]
机构
[1] Salk Inst, Mol & Cell Biol Lab, San Diego, CA 92186 USA
关键词
CD44; methylation; promoter; gene expression;
D O I
10.1007/s00251-001-0417-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Methylation of the CD44 promoter at one or more CpG dinucleotides has been proposed as being important in the control of CD44 expression. In vitro methylation of all CpGs occurring between bases -1 to -1374 upstream of the position of translation initiation repressed the promoter activity of mouse CD44 4.5- to 12-fold in transient transfection experiments. Assaying the methylation of these 29 CpGs by genomic sequencing using differential base modification by sodium bisulfite indicated that a cluster of three CpGs immediately upstream of the position of translation initiation was heavily methylated in the mouse CD44-negative T-cell lymphoma AKRl. All 19 CpGs between bases -4 and -447, including the cluster heavily methylated in AKR1, were demethylated in the CD44-positive T-cell lymphoma BW5147, while CpGs further upstream showed no change in methylation pattern. The cluster of heavily methylated CpGs remained methylated, however, when CD44 was activated by transient transfection of c-jun into an AKR1 subline expressing polyoma large-T or by treatment of this subline with sodium butyrate, and no significant demethylation of other CpGs was observed. It is concluded, therefore, that no consistent demethylation event in the promoter-containing region encompassing the 1374 base pairs upstream of the position of CD44 translation initiation is required for CD44 expression.
引用
收藏
页码:914 / 924
页数:11
相关论文
共 50 条
  • [21] CD44 expression in colorectal neoplasia
    Burns, S
    McMahon, RFT
    JOURNAL OF PATHOLOGY, 1997, 182 : A34 - A34
  • [22] CD44 expression in IgA nephropathy
    Florquin, S
    Nunziata, R
    Claessen, N
    van den Berg, FM
    Pals, ST
    Weening, JJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : 407 - 414
  • [23] CLINICOPATHOLOGICAL SIGNIFICANCE OF CD44, CD44 VARIANTS, AND CD133 EXPRESSION IN SMALL INTESTINAL ADENOCARCINOMA
    Nishimoto, Takayoshi
    Tatsuguchi, Atsushi
    Akimoto, Naohiko
    Yamada, Takeshi
    Hoshimoto, Aitoshi
    Mitsui, Keigo
    Tanaka, Shu
    Gudis, Katya
    Fujimori, Shunji
    Iwakiri, Katsuhiko
    GASTROENTEROLOGY, 2020, 158 (06) : S775 - S775
  • [24] The liberation of CD44
    Cichy, J
    Puré, E
    JOURNAL OF CELL BIOLOGY, 2003, 161 (05): : 839 - 843
  • [25] Micromanaging CD44
    Nicola McCarthy
    Nature Reviews Cancer, 2011, 11 : 156 - 156
  • [26] Expression of CD44 variants in osteosarcoma
    M. Kuryu
    T. Ozaki
    K. Nishida
    M. Shibahara
    A. Kawai
    H. Inoue
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 646 - 652
  • [27] Altered CD44 expression in endometriosis
    Fan, F
    Tawfik, O
    Iczkowski, K
    Nothnick, W
    Thomas, P
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 544 - 545
  • [28] CD44 expression in the human retina
    Nishina, S
    Hirakata, A
    Hida, T
    Sawa, H
    Azuma, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4817 - 4817
  • [29] CD44 expression in the cuprizone model
    Reinbach, Christin
    Stadler, Maria-Sophia
    Proebstl, Nicolas
    Chrzanowski, Uta
    Schmitz, Christoph
    Kipp, Markus
    Hochstrasser, Tanja
    BRAIN RESEARCH, 2020, 1745
  • [30] CD44 surprise
    Gordon, Eva J.
    ACS CHEMICAL BIOLOGY, 2007, 2 (03) : 143 - 143